Considerations for hormone therapy use in survivors of breast cancer.

IF 3 3区医学 Q1 OBSTETRICS & GYNECOLOGY

Menopause: The Journal of The North American Menopause Society Pub Date : 2025-09-02 DOI:10.1097/GME.0000000000002629

Holly J Pederson

引用次数: 0

Abstract

The use of hormone therapy in survivors of breast cancer is complex and contentious. Historically, guidelines have strongly advised against using hormone therapy. Its safety likely depends on many factors. However, long-term oncologic data are lacking, leaving women with unresolved quality-of-life and health concerns and practitioners uncertain about their recommendations. In the short term, there will not be definitive data, and decisions must be made based on the existing imperfect evidence.

查看原文本刊更多论文

乳腺癌幸存者使用激素治疗的考虑。

在乳腺癌幸存者中使用激素疗法是复杂而有争议的。从历史上看，指南强烈建议不要使用激素疗法。它的安全性可能取决于许多因素。然而，由于缺乏长期的肿瘤学数据，妇女的生活质量和健康问题尚未得到解决，从业人员也不确定他们的建议。在短期内，不会有明确的数据，必须根据现有的不完善的证据作出决定。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Menopause: The Journal of The North American Menopause Society 医学-妇产科学

CiteScore

5.40

自引率

7.40%

发文量

330

审稿时长

3-8 weeks

期刊介绍： Menopause, published monthly, provides a forum for new research, applied basic science, and clinical guidelines on all aspects of menopause. The scope and usefulness of the journal extend beyond gynecology, encompassing many varied biomedical areas, including internal medicine, family practice, medical subspecialties such as cardiology and geriatrics, epidemiology, pathology, sociology, psychology, anthropology, and pharmacology. This forum is essential to help integrate these areas, highlight needs for future research, and enhance health care.